Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study.

D'Angelo S, Cantini F, Ramonda R, Cantarini L, Carletto A, Chimenti MS, Delle Sedie A, Foti R, Gerli R, Lomater C, Lubrano E, Marchesoni A, Zabotti A, Salvarani C, Scrivo R, Scarpa R, Tramontano G, Nannini C, Lorenzin M, Fabbroni M, Martinis F, Perricone R, Carli L, Visalli E, Rovera G, Perrotta FM, Quartuccio L, Altobelli A, Costa L, Niccoli L, Ortolan A, Caso F.

Front Pharmacol. 2019 Dec 13;10:1497. doi: 10.3389/fphar.2019.01497. eCollection 2019.

2.

Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study.

Nannini C, Niccoli L, Sestini S, Laghai I, Coppola A, Cantini F.

Ann Rheum Dis. 2019 Oct;78(10):1444-1446. doi: 10.1136/annrheumdis-2019-215585. Epub 2019 Jun 18. No abstract available.

PMID:
31213436
3.

Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study.

Servioli L, Maciel G, Nannini C, Crowson CS, Matteson EL, Cornec D, Berti A.

J Rheumatol. 2019 Jul;46(7):727-730. doi: 10.3899/jrheum.180481. Epub 2019 Jan 15.

PMID:
30647188
4.

Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables.

Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Gobbi FL, Cassarà E, Kaloudi O, Cantini F.

Ther Clin Risk Manag. 2018 Oct 24;14:2097-2111. doi: 10.2147/TCRM.S175772. eCollection 2018.

5.

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs.

Goletti D, Petrone L, Ippolito G, Niccoli L, Nannini C, Cantini F.

Expert Rev Anti Infect Ther. 2018 Jun;16(6):501-512. doi: 10.1080/14787210.2018.1483238. Epub 2018 Jun 12. Review.

PMID:
29848120
6.

Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016.

Maciel G, Servioli L, Nannini C, Berti A, Crowson CS, Achenbach SJ, Matteson EL, Cornec D.

RMD Open. 2018 Feb 28;4(1):e000575. doi: 10.1136/rmdopen-2017-000575. eCollection 2018.

7.

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet's disease after switching from infliximab originator.

Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O.

Eur J Rheumatol. 2017 Dec;4(4):288-290. doi: 10.5152/eurjrheum.2017.16112. Epub 2017 Oct 25.

8.

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics.

Cantini F, Nannini C, Niccoli L, Petrone L, Ippolito G, Goletti D.

Mediators Inflamm. 2017;2017:8909834. doi: 10.1155/2017/8909834. Epub 2017 Jun 1. Review.

9.

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Benucci M, Gobbi FL, Guiducci S, Foti R, Mosca M, Goletti D.

Semin Arthritis Rheum. 2017 Oct;47(2):183-192. doi: 10.1016/j.semarthrit.2017.03.008. Epub 2017 Mar 22. Review.

PMID:
28413099
10.

Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.

Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Rizzello F, Gionchetti P.

J Rheumatol. 2017 Sep;44(9):1341-1346. doi: 10.3899/jrheum.161518. Epub 2017 Apr 15.

PMID:
28412702
11.

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.

Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Biggioggero M, Benucci M, Li Gobbi F, Grossi V, Infantino M, Meacci F, Manfredi M, Guiducci S, Bellando-Randone S, Matucci-Cerinic M, Foti R, Di Gangi M, Mosca M, Tani C, Palmieri F, Goletti D; Italian board for the TAilored BIOlogic therapy (ITABIO).

Semin Arthritis Rheum. 2016 Apr;45(5):519-32. doi: 10.1016/j.semarthrit.2015.10.001. Epub 2015 Oct 22. Review.

PMID:
26607440
12.

Uveitis in Spondyloarthritis: An Overview.

Cantini F, Nannini C, Cassarà E, Kaloudi O, Niccoli L.

J Rheumatol Suppl. 2015 Nov;93:27-9. doi: 10.3899/jrheum.150630. Review.

PMID:
26523051
13.

Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report.

Niccoli L, Cassarà E, Kaloudi O, Nannini C, Romagnoli M, Cantini F.

BMC Musculoskelet Disord. 2015 Jun 14;16:146. doi: 10.1186/s12891-015-0602-6.

14.

Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice.

Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, Sanduzzi A, Matucci A, Prignano F, Conversano M, Goletti D; SAFEBIO (Italian multidisciplinary task force for screening of tuberculosis before and during biologic therapy).

Autoimmun Rev. 2015 Jun;14(6):503-9. doi: 10.1016/j.autrev.2015.01.011. Epub 2015 Jan 21. Review.

PMID:
25617816
15.

Infliximab monotherapy for neuro-Behçet's disease: a case report.

Di Filippo M, Di Gregorio M, Nannini C, Gaetani L, Gallina C, Floridi P, Sarchielli P, Calabresi P, Cantini F.

J Neurol Sci. 2014 Dec 15;347(1-2):389-90. doi: 10.1016/j.jns.2014.09.052. Epub 2014 Oct 7. No abstract available.

PMID:
25456463
16.

Primary Sjogren's syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality.

Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL.

BMJ Open. 2013 Nov 25;3(11):e003569. doi: 10.1136/bmjopen-2013-003569.

17.

Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study.

Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL, Bongartz T.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1243-50. doi: 10.1002/acr.21986.

18.

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study.

Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C.

Biologics. 2013;7:1-6. doi: 10.2147/BTT.S31474. Epub 2013 Jan 4.

19.

Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study.

Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C.

Biologics. 2012;6:201-6. doi: 10.2147/BTT.S31145. Epub 2012 Jul 12.

20.

Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study.

Niccoli L, Nannini C, Cassarà E, Kaloudi O, Susini M, Lenzetti I, Cantini F.

Int J Rheum Dis. 2012 Aug;15(4):414-8. doi: 10.1111/j.1756-185X.2012.01736.x. Epub 2012 Apr 29.

PMID:
22898222
21.

Infliximab in psoriatic arthritis.

Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E.

J Rheumatol Suppl. 2012 Jul;89:71-3. doi: 10.3899/jrheum.120249. Review.

PMID:
22751598
22.

Patient-reported outcomes in polymyalgia rheumatica.

Matteson EL, Maradit-Kremers H, Cimmino MA, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Slott Jensen H, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Cantini F, Nannini C, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazelman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Marcus R, Gonter NJ, Maz M, Crowson CS, Dasgupta B.

J Rheumatol. 2012 Apr;39(4):795-803. doi: 10.3899/jrheum.110977. Epub 2012 Mar 15.

23.

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL.

Arthritis Rheum. 2012 Apr;64(4):943-54. doi: 10.1002/art.34356.

24.

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Amo MD, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL.

Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329.

25.

Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes.

Niccoli L, Nannini C, Cassarà E, Kaloudi O, Cantini F.

Int J Rheum Dis. 2012 Feb;15(1):56-61. doi: 10.1111/j.1756-185X.2011.01662.x. Epub 2011 Sep 14.

PMID:
22324947
26.

Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients.

Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I.

Biologics. 2012;6:5-12. doi: 10.2147/BTT.S27343. Epub 2011 Dec 29.

27.

Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?

Romagnoli M, Nannini C, Piciucchi S, Girelli F, Gurioli C, Casoni G, Ravaglia C, Tomassetti S, Gurioli Ch, Gavelli G, Carloni A, Dubini A, Cantini F, Chilosi M, Poletti V.

Eur Respir J. 2011 Aug;38(2):384-91. doi: 10.1183/09031936.00094910. Epub 2011 Jan 27.

28.

Psoriatic arthritis: a systematic review.

Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassarà E.

Int J Rheum Dis. 2010 Oct;13(4):300-17. doi: 10.1111/j.1756-185X.2010.01540.x. Review.

PMID:
21199465
29.

Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.

Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL.

Arthritis Rheum. 2010 Jun;62(6):1583-91. doi: 10.1002/art.27405.

31.

Efficacy of infliximab therapy in two patients with refractory Vogt-Koyanagi-Harada disease.

Niccoli L, Nannini C, Cassarà E, Gini G, Lenzetti I, Cantini F.

Br J Ophthalmol. 2009 Nov;93(11):1553-4. doi: 10.1136/bjo.2008.153981. No abstract available.

PMID:
19854741
32.

Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs.

Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, Salvarani C.

J Rheumatol Suppl. 2009 Aug;83:78-80. doi: 10.3899/jrheum.090234.

PMID:
19661551
34.

Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.

Nannini C, Crowson CS, Matteson EL, Moder KG.

Lupus. 2009 Apr;18(5):394-9. doi: 10.1177/0961203308099242.

PMID:
19318390
35.

Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.

Nannini C, West CP, Erwin PJ, Matteson EL.

Arthritis Res Ther. 2008;10(5):R124. doi: 10.1186/ar2534. Epub 2008 Oct 20. Review. Erratum in: Arthritis Res Ther. 2009;11(2):408.

36.

Effort angina in a patient with advanced coronary artery disease. Role played by coronary angiography, Ivus and cardiac CT: case report.

Zardi DM, Zardi EM, Berni A, Nannini C, Pace BA, Santucci S, Volpe M.

Cardiovasc Ultrasound. 2008 Sep 24;6:48. doi: 10.1186/1476-7120-6-48.

37.

Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.

Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, Salvarani C.

Rheumatology (Oxford). 2008 Jun;47(6):872-6. doi: 10.1093/rheumatology/ken059. Epub 2008 Apr 9.

PMID:
18400836
38.

Lung disease in rheumatoid arthritis.

Nannini C, Ryu JH, Matteson EL.

Curr Opin Rheumatol. 2008 May;20(3):340-6. doi: 10.1097/BOR.0b013e3282f798ed. Review.

PMID:
18388528
39.

Diagnosis and treatment of giant cell arteritis.

Cantini F, Niccoli L, Nannini C, Bertoni M, Salvarani C.

Drugs Aging. 2008;25(4):281-97. Review.

PMID:
18361539
40.

Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described.

Cantini F, Niccoli L, Nannini C, Chindamo D, Bertoni M, Cassarà E, Salvarani C.

Ann Rheum Dis. 2007 Dec;66(12):1672-4. Epub 2007 Sep 3.

41.

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.

Niccoli L, Nannini C, Benucci M, Chindamo D, Cassarà E, Salvarani C, Cimino L, Gini G, Lenzetti I, Cantini F.

Rheumatology (Oxford). 2007 Jul;46(7):1161-4. Epub 2007 May 3.

PMID:
17478466
42.

Primary angioplasty and routine utilization of thrombus aspiration devices: feasibility and results in a consecutive series of 486 patients.

Varbella F, Gagnor A, Luceri S, Bongioanni S, Nannini C, Masi AS, Tripodi R, Pron PG, Mainardi L, Badalì A, Conte MR.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):258-64.

PMID:
17413302
43.

Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.

Cantini F, Niccoli L, Benucci M, Chindamo D, Nannini C, Olivieri I, Padula A, Salvarani C.

Arthritis Rheum. 2006 Oct 15;55(5):812-6. No abstract available.

44.

Inflammatory changes of hip synovial structures in polymyalgia rheumatica.

Cantini F, Niccoli L, Nannini C, Padula A, Olivieri I, Boiardi L, Salvarani C.

Clin Exp Rheumatol. 2005 Jul-Aug;23(4):462-8.

PMID:
16095113
45.

Pulmonary hypertension in primary Sjögren's syndrome: report of a case and review of the literature.

Bertoni M, Niccoli L, Porciello G, Storri L, Nannini C, Manes A, Palazzini M, Galiè N, Cantini F.

Clin Rheumatol. 2005 Aug;24(4):431-4. Epub 2005 May 19. Review.

PMID:
15906110
46.

[Primary angioplasty in a patient with the May-Hegglin anomaly, a rare heredity thrombocytopenia. A case report and review of the literature].

Varbella F, Bongioanni S, Gagnor A, Nannini C, La Brocca A, Badalì A, Conte MR.

Ital Heart J Suppl. 2005 Apr;6(4):214-7. Review. Italian.

PMID:
15902944
47.

[Initial experience in the management of myocardial infarction with primary angioplasty: results of the activity in two hospitals of the Turin area without on-site cardiac surgery].

Varbella F, Giammaria M, Belli R, Nannini C, Ierna S, Badalì A, Beqaraj F, Giay Pron P, Bongioanni S, Gagnor A, Trinchero R, Conte MR.

Ital Heart J Suppl. 2004 Nov;5(11):847-54. Italian.

PMID:
15633428
48.

Are polymyalgia rheumatica and giant cell arteritis the same disease?

Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, Boiardi L, Salvarani C.

Semin Arthritis Rheum. 2004 Apr;33(5):294-301. Review.

PMID:
15079760
49.

Fat suppression magnetic resonance imaging in shoulders of patients with polymyalgia rheumatica.

Cantini F, Salvarani C, Niccoli L, Nannini C, Boiardi L, Padula A, Olivieri I, Valentino M, Barozzi L.

J Rheumatol. 2004 Jan;31(1):120-4.

PMID:
14705230
50.

Encephalopathy associated with Hashimoto's thyroiditis: an additional case.

Bertoni M, Falcini M, Sestini S, Niccoli L, Nannini C, Cantini F.

Eur J Intern Med. 2003 Nov;14(7):434-437.

PMID:
14614977

Supplemental Content

Loading ...
Support Center